fluffybingo| The concept of synthetic biology fluctuates and rebounds. Shengda Biotech's daily limit

Topic: A-shares have entered a right-side rising stage. Foreign investment is optimistic about the allocation value of A-shares

May 24 newsfluffybingo, the concept of synthetic biology fluctuated and rebounded in early tradingfluffybingo, Shengda Biotech's daily limit rose, followed by Boen Group, Kyodo Pharmaceutical, Fujiilai, Azure Biotech, etc.

On the news front, Beijing released the "Beijing City Action Plan to Accelerate Collaborative Innovation in Medicine and Health (2024-2026)." The "Action Plan" proposes to deploy "nuclear explosion point" special projects in cutting-edge technology fields such as cell gene therapy, brain-computer interfaces, and synthetic biology.

Tags:

Prev: pokerknight| Putin signs the order! Allow the confiscation of U.S. assets to compensate Russia for losses
Next: wemixcharacternft| Xuzhou Metro Group's 2.5 billion yuan private equity project status updated to "terminated"